Russia Reboots Animal Vaccine Production After Livestock Culling

A sweeping decree reshapes the landscape of veterinary medicine in Russia, following a devastating cattle outbreak that claimed thousands of lives in Siberia.

The Trigger

Cattle Outbreak
A mutated pathogen swept through the Novosibirsk region, causing a catastrophic loss of livestock.
Public Outcry
The crisis sparked protests and unprecedented calls for top officials to resign—a rare move in wartime Russia.

Key Provisions of the Decree

Action	Purpose
Merge state‑owned firms into the Russian Biological Industry Company (RBIC)	Increase independence and attract investment in veterinary medicine
Boost domestic vaccine production	Cut reliance on foreign technology and secure supply chains

Domestic Production Surge

Pre‑Sanctions (2022): Russia sourced up to 70% of animal vaccines from abroad.
Post‑Sanctions: The same 70% is now produced domestically, thanks to a planned tenfold increase at Shchelkovo Biokombinat in 2024.

International Concerns

U.S. Department of Agriculture: Suggested a possible foot‑and‑mouth disease outbreak, raising doubts about vaccine quality and trade risks.
Russian Regulators: Countered that foot‑and‑mouth shots have been routine since 2022, denying any such claim.

Farmer’s Perspective

Farmers attribute the outbreak to irregular vaccination practices on small farms, which allowed the mutated pathogen to spread beyond regional borders.

Strategic Goal

Secure Supply Chain
Reduce dependence on foreign technology and stabilize veterinary healthcare amid geopolitical tensions.